Vaccines Congress 2019 extends the heartiest welcome to proficient delegates, scientists, professors, students, young researchers, business executives, scholars, chemists and professionals across the globe to be a part of “5th World Vaccine and Immunology Congress", during June 10-11, 2019, to be held at Bangkok, Thailand. Keynote presentations, exhibitions, oral talks and poster presentations outline the key attractions of the conference on the theme "Promulgate a vision in the field of vaccines and immunology."
Vaccines Congress 2019 along with 500+ Conferences organized across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contain over 30000 eminent personalities as editorial board members.
We invite you to join us at the Vaccines Congress 2019 Conference, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Vaccines Congress 2019 organizing committee look forward to meeting you in Bangkok, Thailand.
· Eminent personalities
· Head of Departmental
· Presidents/Vice Presidents
· CEO's of biotech companies
· Professors, Associate and Assistant professors
· Research Scholars and students from the related fields
· Other experts in Vaccines
Only Registration Includes
01. Access to all Sessions
02. Handbook & Conference Kit
03. Certificate Accreditation by the International Organizing Committee Members (IOCM)
04. Abstracts will be published in the conference souvenir and respective international journal
05. Each registrant will get 50% abatement on manuscript publication fees
06. Ask the Expert Forums (One to One Pre-Scheduled meeting on interest and availability)
07. 10% abatement on the registration fees for the next annual conference
08. 10% abatement on the membership of the International conference
09. 2 Coffee breaks (refreshments and snacks) during the conference
10. Lunch during the conference
Package A: Above 11 features including the following...
12. Breakfast during the Conference
13. 02 Night’s accommodation (i.e. June 9th & 10th) in the deluxe single/double room at the conference venue
Package B: Above 13 features including the following...
14. 1 Night extra accommodation i.e. June 11th (total 3 nights)
Discounts are available on Group Registrations
20% discount available on a group of 10+ members.
About Vaccines Congress 2019
Organizing Committee every year hosts interdisciplinary international conferences worldwide on cutting-edge basic and applied research in life sciences, Pharma, medicine, healthcare and nursing delivered by the best talents in industry and academia. Our conferences are oriented to drive the scientific community at large, facilitating access to the newest technical and scientific achievements and to shape future research directions through the publication of applied and theoretical research findings of the highest quality.
Vaccines Congress 2019 aims to unite the Professors, researchers, business mammoths, and technocrats to give a global gathering to spread of unique research comes about, new thoughts and viable improvement and find progresses in the field of Vaccine, Immunization and Vaccination, administration and instruction in connection to Vaccine, Immunization and vaccination and additionally an expansiveness of different subjects.
This meeting makes a stage for Policy-creators, Scientists, agents and leaders in Vaccine, Immunization, and Vaccination to display their most recent research and finds out about all the imperative advancements in Vaccine, Immunization, and Vaccination. Real subjects talked about are Latest developed vaccines, Production and effectiveness of vaccines, Types of vaccines, Veterinary vaccines, Paediatric vaccines, Vaccines against drugs, Vaccines and autism, Vaccines for unconventional diseases, Animal and plant-derived vaccines, Vaccines safety and efficiency, Current research and future challenges in vaccines, Society and cultural aspects of vaccines.
Vaccines Congress 2019 gives a worldwide stage to trading thoughts and makes us overhauled about the most recent advancements in the field of Vaccine, Immunization, and Vaccination. The chance to go to the presentations conveyed by Eminent Scientists from everywhere throughout the world.
• Meet experts and influences face to face.
• Conferences provide a great opportunity to a network where most people can help each other uncover ideas and spark inspiration.
•To learn new things in your field
• Conferences Build Your Knowledge Base
• Encounter new vendors and suppliers
• Attending a conference allows you to grow and challenge yourself
• Attending conferences grow your professional network
• Position your company as a champion
• Network with leaders and influencers from the scientific, academic and R&D communities
Organizing Committee invites all the participants from all across the globe to attend "5th World Vaccine and Immunology Congress”, on June 10-11, 2019 in Bangkok, Thailand which includes prompt keynote presentations, poster presentations, oral talks, and exhibitions.
Sessions and Tracks
Session 1: Vaccination and Immunisation
A vaccination is the injection of a killed or weakened organism to boost the immune system’s ability to fight against that organism. Vaccination is a suspension of attenuated or killed microorganisms that are administered for the prevention or treatment of infectious disease. The vaccination helps the immune system to recognize and fight specific germs. Perfect immunity against a disease is not guaranteed through vaccination. Immunization refers to making someone immune to infections or diseases. Immunization is not only caused by vaccines but there are also some diseases that cause immunization after an individual encounters and recovers from that disease.
• Active Immunization
• Passive Immunization
• Chickenpox vaccine
• Diphtheria, Tetanus, Pertussis, and Polio vaccine
• Haemophilus influenza type b vaccine
• Hepatitis B vaccine
• Influenza vaccine
• Measles, Mumps, and Rubella vaccine
• Meningococcal vaccine
• Pneumococcal vaccine
Session 2: Vaccines and Vaccination
A vaccine is a biological formation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that features a disease-causing microorganism and is often made from weakened or killed forms of the micro-organism, its toxins, or one of its surface proteins. Vaccines create immunity against a disease. The traditional vaccine consists of agents that resemble the disease-causing organism. When these agents enter the human body they stimulate the immune system to recognize these agents as foreign and destroy them. It also makes the immune system remember these foreign agents so that they can recognize and destroy the real live virulent germs. A vaccine can be administered into the body through injections, by mouth or by aerosol.
Following are the issues majorly studied in vaccines.
• Vaccine Safety
• Vaccine Work
• Vaccine Type
• Vaccine Ingredients
Session 3: Pathology and Immunology
Pathology is a branch of medical science primarily concerning the examination of organs, tissues, and bodily fluids in order to make a diagnosis of disease. Immunopathology is a branch of biomedical science concerned with immune responses to disease, with immunodeficiency diseases, and with diseases caused by immune mechanisms. It includes the study of the pathology of an organism, organ system, or disease with respect to the immune system, immunity, and immune responses. The immune pathological reaction is caused by a release of toxins and the apoptosis of infected cell.
• Innate Immunity
• Adaptive immunity
• T cells and APCs
• Antibody-mediated immunity
• Cell-mediated Immunity
• Passive immunisation
Session 4: Types of vaccines
Depending on the strategies used to reduce the risk of illness caused by a vaccine, while retaining their ability to induce a beneficial immune response they are classified into various types. The human vaccines against viruses were made using weaker or attenuated viruses whereas a smallpox vaccine is made of cowpox, a poxvirus similar enough to smallpox virus to create immunity. Several different processes are involved in vaccine production based on which they are classified into different types.
• Live Attenuated Vaccines
• Inactivated/ Killed Vaccines
• Toxoid Vaccines
• Subunit/ Conjugate Vaccines
• Heterotypic Vaccines
Session 5: Vaccines against Viral & Bacterial Diseases
Vaccination is distinct as acquired immunity fashioned by immunogen. Its resistance and immunological retention comparable to natural infection however bereft of a risk of illness. Microorganism vaccines contain killed or attenuated bacterium that activates the system. Antibodies area unit engineered against that specific bacterium and prevents microorganism infection later. A vaccine-derived from bacteria is named as microorganism immunogen and from the virus is as infective agent immunogen. The following immunogen organism retains the power to duplicate and turn out immunity, however typically doesn't cause malady. Most vaccines against microorganism infections area unit effective at preventing sickness, reactions will occur once vaccinations.
•Vaccines against vector-borne diseases
•Tetanus, Diphtheria, one-celled respiratory illness immunogenic
•Human papillary tumour virus immunogenic
•Vaccines formulation and technologies utilized in conjugated vaccines
•Vaccines for reaction skin disorders & neuropathies
Session 6: Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy exemplifies an exciting cancer treatment which stimulates a patient-specific immune response against cancer by making use of a virus’ ability to replicate and kill tumour tissue selectively. Immune stimulating chemicals are produced by genetically modifying the Oncolytic Viruses which also makes them more specific for cancer cells. Therapeutic cancer vaccines and mAb therapy are some of the cancer immunotherapies with which Oncolytic virus immunotherapy are often combined.
• Engineering Oncolytic viruses
• The oncolytic behaviour of wild-type viruses
• Tumour cell phenotype
• Inherent tumour physiology
Session 7: Clinical and Vaccine Immunology
Clinical Immunology deals with the study of diseases and disorders that occurs as a result of a weak immune system which includes aberrant action, failure, and abnormal growth of the cellular elements of the immune system. It also deals with diseases related to other systems, where immune responses play a role. Vaccine Immunology deals with the study of vaccines and their immunological effects. It deals with immunological vaccines, their synthesis, development and therapeutic desirability and compatibility.
• Cellular and Humoral immunity
• Immunological and Immune-mediated disorders
• Microbial immunology
• Viral immuno-pathogenesis
Session 8: Preventive and Therapeutic Cancer Vaccines
The vaccine that prevents an infection which causes cancer is Preventive Cancer Vaccines. Some of the preventive vaccines available include the HPV vaccines and hepatitis B vaccines which prevents cervical, anal, and head and neck cancers. On the other hand, the vaccines that trigger the immune system to recognize and destroy certain markers, or antigens, present on or in cancer cells are termed as Therapeutic Cancer Vaccines
• Vector-based vaccines
• Dendritic cell
• Antigen vaccines
• Tumour cell vaccines
• DNA Vaccines
• Protein or Peptide Cancer Vaccines
• Allogeneic cancer vaccines
• Autologous cancer vaccines
Session 9: Disorders related to immunology
Immune system disorders cause abnormally low activity or bodily function of the system. In cases of system bodily function, the body attacks and damages its own tissues (autoimmune diseases). Immune deficiency diseases decrease the body's ability to fight invaders, inflicting vulnerability to infections. In a way, over eighty diseases happen to owe to the system assaulting the body's own organs, tissues, and cells. A number of the additional common reaction diseases like diabetes, autoimmune disease, general LE, and inflammatory internal organ malady. Despite the actual fact that the explanations for a few system diseases keep obscure, a man's genes in an exceedingly combine with contaminations. Treatments square measure offered for several reaction diseases; however, cures have nevertheless to be discovered.
• Autoimmune disease
• General LE
• Inflammatory internal organ malady
• disseminated sclerosis
• Chronic inflammatory demyelinating polyneuropathy
• Disease of the skin.
• Graves' disease
• Hashimoto's rubor
• Disease of the neuromuscular junction
Session 10: Stem Cell Immunology
The capacity of the pluripotent stem cells is of great advantage to repair tissues, cell replacement therapeutics for treating chronic or degenerative diseases. There are chances of developing immunogenicity in response to stem cell therapy which may cause severe adverse and fatal effects to an individual. Hence various measures and strategies are being developed for the effective control of stem cell immunogenicity.
• Embryonic Stem Cells
• Cell medical care
• Allogeneic Immune Rejection
• Immune Tolerance
• Pluripotent Stem Cells
• Stem Cell Transplantation
• Major organic phenomenon complicated
Session 11: Vaccines for Pregnant Women & Neonates
Immunization throughout physiological condition has the potential to guard the mother and therefore the baby against immunogenic preventable diseases. One of the aims is the protection of pregnant girls is to extend the number of maternal protein (proteins that fight disease) transferred to infants and protect them from communicable disease. Vaccination plays a vital role in the health of a mother and therefore the baby. There’s a profit for ladies to be immunised to cut back their probabilities of morbidity and mortality from vaccine-preventable diseases. Before administering an immunogen to a pregnant lady, the prenatal health care supplier should recognize the immunogenic material within the immunogen. Live, attenuated virus vaccines, like the MMR immunogen or the nasally delivered flu immunogen, aren't suggested in physiological condition.
• Pregnancy & Hepatitis B
• Pregnant Women & Influenza (Flu)
•A pregnancy and Whooping Cough
•Before Pregnancy: Rubella, Measles, Mumps, Chickenpox
•Pregnancy & MMR
•Pregnancy & Pneumococcal
Session 12: Geriatric Immunization
As we get older, our immune system tends to weaken over time, putting us at higher risk for certain diseases. This is why, in addition to seasonal flu (influenza) vaccine and Td or T dap vaccine (tetanus, diphtheria, and pertussis), the adults 60 years or older should take Pneumococcal vaccines, which protect against pneumococcal diseases, including infections in the lungs and bloodstream (also recommended for adults younger than 65 years who have certain chronic health conditions) and Zoster vaccine, which protects against shingles.
• Flu shots for seniors
• Immunization schedule for elderly people
• Immunization and its side effects in geriatrics
• Vaccine dosing and administration in older adults
• Herpes zoster vaccines
• Pneumococcal polysaccharide vaccines
• Contraindications and precautions during vaccination in geriatrics
• Risk factors in geriatric immunization
Session 13: Flu, Allergy & Asthma Vaccines
The most common allergies like hay fever or house-dust mite allergy are treated using allergy vaccines. Allergy vaccines are more ejective in treating insect stings like bee and wasp stings, which can be fatal in severe cases. Hypersensitivity reaction vaccines square measure additional ejective in treating insect stings like bee and wasp stings, which may be fatal in severe cases. The hypersensitivity reaction vaccination is employed by graduated doses begins with terribly little dose and it will increase step by step.
Session 14: Vaccines Clinical Trails
Conveyance of associate degree protein in a very program, as an example, enlarged Program on immunisation is that the final product of years of revealing and advancement. Simply a modest level of challenger antibodies advances to authorizing, creating the expenses of immunisation analysis and Development surprisingly high.
1. Pre-clinical advancement is inquiring regarding completed in science laboratory measures and on creatures.
2. Clinical improvement is that the purpose at that the protein is 1st tried in individuals. It covers four phases over quite a long whereas, from beginning clinical trials in individuals (stage I) directly through to presentation and past.
•Current Challenges in vaccine R & D
•Current Focus on medicine analysis
•Regulatory and Economic Aspects in medicine
•Viral genetic science and genetics
Session 15: Travel and Edible Vaccines
Travel vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travellers and to prevent disease spread within and between countries. There is no single vaccination schedule that fits all travellers. Each schedule must be individualized according to the traveller’s previous immunizations, health status, and risk factors, the countries to be visited, the type and duration of travel, and the amount of time available before departure. Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socio-cultural readily acceptable vaccine delivery system, especially for the poor developing countries. It involves the introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins.
• Development of edible vaccines
• Application of edible vaccines
• Candidates for edible vaccines
• Advantages of edible vaccines
• Pre-travel vaccination and its wider impact
Session 16: Veterinary Vaccines
Considerable progress has been made in the production of veterinary vaccines whether live or inactivated for animal use during the past two decades with the increasing use of continuous cell lines as a substrate and adoption of the fermenter technology for antigen production. These vaccines are produced for administration to domestic animals or wild species by parenteral or oral routes according to vaccine characteristics. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parentally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA. Trials are underway for the oral immunization of dogs in developing countries.
• Second-generation veterinary vaccines
• Highly immunogenic inactivated cell culture vaccines
• The third generation of live rabies vaccines
• Live or inactivated veterinary vaccines
• Veterinary vaccines for parenteral use
• Modified live-virus veterinary vaccines for oral immunization of wildlife
• Recombinant veterinary vaccines for oral immunization of wildlife
Session 17: Vaccines and Autism
Vaccinations may be one of the triggers for autism. Substantial data demonstrate an immune abnormality in many autistic children consistent with impaired resistance to infection. Impaired resistance may predispose to vaccine injury in autism. A mercurial preservative in Childhood Vaccines, thimerosal, may cause direct neurotoxic, immune-depressive, and autoimmune injury and contribute to early-onset and regressed autism. Live viruses in measles, mumps, and rubella (MMR) may result in chronic infection of the gut and trigger regressed autism. Thimerosal injection may potentiate MMR injury.
• Autism-vaccines hypothesis
• Live viruses in measles, mumps, and rubella (MMR)
• Vaccines containing thimerosal
• Simultaneous administration of multiple vaccines
• Autoimmunity in autism
• Depressed resistance in autism
Session 18: Immunization and Bioterrorism
Bioweapons threat could include the deliberate release of a biological agent by attackers that causes one or more variety of different diseases. The use of effective vaccines would likely to protect lives and limit disease spread in a biological weapons emergency. Licensed vaccines are currently available for a few threats, such as anthrax and smallpox, and research is underway to develop and produce vaccines for other threats, such as tularemia, Ebola Virus, and Marburg virus. Many bioweapon disease threats, however, lack a corresponding vaccine, and for those that do, significant challenges exist for their successful use in an emergency situation.
• Anthrax and Smallpox
• Plague and Tularaemia
• Ebola, Marburg, Lassa, and Machupo Virus
• Q fever, Ricin toxin, Typhus fever
• Nipah virus
Session 19: Transplant Immunology
The transplant immunology is more about the rejections that take place during the transplantations. It is the study of the immunologic reaction of a recipient due to transplanted organs or tissues from a histo-incompatible recipient. The immune response depends on the presence of antigens in the grafted tissue. If these antigens are absent in the recipient it is recognized as a foreign substance.
The transplant rejection can be reduced by taking the immunosuppressive drugs before and after transplantation and checking the match between the donor and recipients. The transplant rejection is the response of the adaptive immune system by both cellular immunity and humoral immunity.
•Clinical Transplantation diagnostic assay
The recent advancements in vaccines defend the folks from the wide range of diseases. The most ability of the vaccines is to induce the body substance protein responses and cell-mediated responses against the big selection of pathogens. To boot, the invention is accustomed to turning out the vaccines, immunogens and valuable therapeutic and diagnostic reagents. Recent years have witnessed each success and failures of novel immunizing agent style and therefore the strength of reiterative approaches is progressively appreciated the revelation of vaccinations has provoked to the nearby demolition of a couple of basic diseases and has enormously influenced prosperity for a decently insignificant exertion. Regardless, most antibodies being utilized today were created by frameworks that were initiated more than 100 years earlier and don't address the greatest limit of the field. The introduction of an innate building has controlled quick advances in counteracting agent development and is as of now provoking to the entry of new things in the business focus.
Session 21: Paediatric Vaccination
Immunization against diseases such as Polio, Tetanus, Diphtheria, and Pertussis saves the lives of approximately three million children each year. Immunization also prevents many more millions from suffering debilitating illness and lifelong disability. Globally, approximately 132 million babies need to be fully immunized each year. In order to meet this need, immunization systems must have adequate resources, trained and motivated staff, and ample vaccines and syringe supplies.
• Chickenpox vaccination
• 5-in-1 vaccines
• Pneumococcal or Pneumo Jab (PCV) vaccines
• Rotavirus vaccines
• Serogroup B meningococcal (MenB) vaccines
• Hib/Meningitis C booster vaccines
• MMR vaccines
• 4-in-1pre-school booster
• HPV vaccines (girls only)
• Gastro-intestinal vaccination
• Severe reactions to foods, insect stings, and medications (anaphylaxis)
• Neonatal respiratory syncytial virus infection vaccine
Session 22: Current research and future challenges
Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine the discovery of novel antigens, adjuvants, and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines, and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.
• Immunological challenges
• Antigen discovery
• Immunization routes
• Aspects of pathology and host responses
• Expanded testing and modelling of vaccine
• Chloroplast-derived vaccines antigens and therapeutics
• Chloroplast-derived viral antigens
Session 23: Vaccines Business and Research Development
Collaboration plays a significant half within the success of Vaccines Business. This is often exemplified within the relationships engineered, the product launched and lives improved.
Vaccines Business development: comprise a variety of tasks and processes typically aiming at developing and implementing growth opportunities among and between organizations. It’s a set of the fields of business, commerce and structure theory. Vaccine development programs face many challenges that set them with the exception of different varieties of aid development programs. The revelation of vaccinations has aggravated to the close demolition of a handful of basic diseases and has hugely influenced prosperity for the right way insignificant elbow grease. Regardless, most antibodies being utilised these days were created by frameworks that were initiated quite one hundred years earlier and do not address the best limit of the sphere. The introduction of an innate building has controlled fast advances in counteracting agent development and currently provocative to the entry of the latest things within the business focus.
Session 24: Plant-Based Vaccines
The vaccines in which the desired genes that encode the antigen protein for a particular disease are inserted into the genome of plant tissue by various methods are termed as a plant-based vaccine. The most common methods that are used to produce effective plant-based vaccines are Agrobacterium-mediated gene transfer and Transformation via genetically modified plant virus. However, advancements in the field of science and technology developed new approaches such as agroinfiltration, biolistics, electroporation, polyethene glycol treatment and sonication to replace the former methods.
• Plant-Based Vaccines Production
• Direct & Indirect Gene Delivery Method
• Immunogenic Design and Gene Synthesis
• Methods to Increase the Efficiency of Gene Delivery
• Challenges of Plant-Based Vaccines
• Plastid transformation
Session 25: Vaccine Delivery Systems and Adjuvants
Immunization adjuvants are expected to boost the versatile unpersuadable reactions to antigens. Adjuvants demonstrate their belongings through varied instruments. A couple of adjuvants fill in as conveyance frameworks that offer incitement of the resistant framework. Medicine adjuvants are additional to antibodies for the incitement of the reaction of a secure framework to the target substance; nevertheless squarely do not offer insusceptibility. Adjuvants might act in several approaches to show associate degree substance within the resistant framework. These vaccines usually should be created with adjuvants to confirm the body produces associate degree immunologic response sturdy enough to shield the patient from the germ he or she is being insusceptible against. Al gels or Al salts are immunizing agent ingredients that are utilized in vaccines since the Nineteen Thirties. Little amounts of Al are added to assist the body build stronger immunity against the germ within the immunizing agent. Al is one in all the foremost common metals found in nature and is a gift in the air, food, and water. The quantity of Al gift in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).
Market Analysis Report
Global Market Analysis
Vaccines Congress 2019 welcomes attendees, presenters and exhibitors from all over the world to Bangkok, Thailand. We are delighted to invite you all to attend and register for the “5th World Vaccines and Immunology Congress ” which is going to be held during June 10-11, 2019 Bangkok, Thailand.
The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. All members of the organizing committee look forward to meeting you in Bangkok, Thailand.
Importance & Scope:
The vaccines market was USD 34.30 Billion in 2017, at a CAGR of 7.5% and is expected to reach USD 114.2 Billion by 2028. The CAGR for the Global Vaccines Sales market from 2018-2028 is expected to be 10.9%. The vaccine market has a growth due to increase in prevalence in diseases, increase in government, non-government and industrial funding. The prospective signifies a major growth in the vaccine market but due to high costs associated with the vaccine development, the market growth may be retarded.
Vaccines market provides all the inclusive details of the global market, particularly in North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The CAGR is expected to be the highest in the North American region followed by the Asia Pacific and Europe is accounted to be the third largest market, over the forecast period.
Association and societies
Other Healthcare Professionals
- Vaccine Developers and Investigators
- Vaccine & Immunology Emeritus Professors
- Immunology Researchers
- Vaccine & Immunology Scientists
- Vaccine & Immunology Professors
- Chairmen, CEOs, Presidents, Vice-presidents, Directors, Deans, Research Scholars
- Medical faculty & staff
- Clinical Microbiologists
- Associations and Societies related to Vaccine R&D
- Immunology societies & Associations
- Vaccines Training Institutes
- Medical Devices Companies
- Vaccine Manufacturing Companies
- Clinical Data Management Companies
- Medical Equipment Companies
Major associations around the Globe for Vaccine and Immunology Research
- European Society for Immunodeficiency
- American Association of Immunologists
- American Association of Veterinary Immunologists
- Australasian Society for Immunology
- British Society for Immunology
- The International Union of Immunological Societies
- The Society for Travel Immunology
- British Society for Immunology
- European Federation of Immunological Societies
- Federation of African Immunological Societies
- Federation of Clinical Immunology Societies
- Immune Deficiency Foundation
Vaccines Congress 2018 Report
2nd World Vaccines and Immunology Congress were organized on October 15-16, 2018 at the Raddison Hotel Narita, Tokyo, Japan. The conference was marked with the attendance of Editorial Board Members of supported Scientists, young and brilliant researchers and talented student communities representing more than 10 countries, who made this conference fruitful and productive.
This conference was based on the Theme - " Explore the Intriguing Ideas in the Arena of Vaccines” which included the following scientific tracks:
1. Vaccines and Vaccination
2. Types of vaccines
3. Vaccination and Immunisation
4. Clinical and Vaccine Immunology
5. Vaccine Preventable Diseases
6. Plant-based Vaccines
7. Oncolytic Virus Immunotherapy
8. Preventive and Therapeutic Cancer Vaccines
9. Vaccine Adjuvants
10. Vaccines Delivery System
11. Biotechnology and Modern Vaccine Technology
12. Vaccine Development and Production
13. Travel and Edible Vaccines
14. Veterinary Vaccines
15. Geriatric Immunization
16. Current research and future challenges
17. Vaccines and Autism
18. Immunization and Bioterrorism
19. Vaccines against Drugs
20. Paediatric Vaccination
Vaccines Congress 2018 was moderated by Eduardo J Simoes (University of Missouri School of Medicine, USA) on the First and Second day of the Conference by Uraiwan Intamaso (Burapha University, Thailand).
We are grateful to our Organizing Committee Members for their generous support and suggestions for the conference.
1. Tirasak Pasharawipas– Rangsit University, Thailand
2. Davud A Devrishov– Moscow State Academy of Veterinary Medicine and Biotechnology- MVA K. I. Skryabin, Russia
3. Pierre A Morgon –MRGN Advisors, Switzerland
4. Gerardo Guillén –Centre for Genetic Engineering and Biotechnology, Cuba
The conference proceeded through various Scientific Sessions and plenary lectures, of which the following topics were highlighted as Keynote Presentations and oral presentation:
· The access to produce compatible viral vaccines for individuality – Tirasak Pasharawipas, Rangsit University, Thailand
· The present and future of vaccinal prevention of animal brucellosis: Davud A Devrishov, Moscow State Academy of Veterinary Medicine and Biotechnology-MVA K. I. Skryabin, Russia
· Successfully activating positive behaviours of the stakeholders involved in vaccine purchasing and usage through technological advances: Pierre A Morgon, MRGN Advisors, Switzerland
· Virus-like particles and nucleoparticles as a vaccine candidate: Gerardo Guillén, Center for Genetic Engineering and Biotechnology, Cuba
Scientific sessions were chaired on Day 1 by Vaclav Bunc, Charles University, Czech Republic and as Co-Chair by Orlando Leite de Carvalho, The Santa Marcelina Hospital, and on Day 2 chaired by Davud A Devrishov, Moscow State Academy of Veterinary Medicine and Biotechnology-MVA K. I. Skryabin, Russia and Co-Chaired by Tirasak Pasharawipas, Rangsit University, Thailand
A grand privilege of felicitating Vaccines Congress 2018 Organizing Committee, Editorial Board Members and Keynote Speakers who supported the success of this event.
The esteemed guests, Keynote speakers, well-known researchers, and delegates shared their innovative research and vast experience through their presentations at the podium of Vaccines Congress 2018. We are glad to inform that all accepted abstracts for the conference have been published in the Biomedical Research as a special issue.
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique and positive feedback from the conference, We would like to announce the commencement of the “5th World Vaccines and Immunology Congress " which is being organized during June 10-11, 2019 at Bangkok, Thailand.